Background: While most patients with mild cognitive impairment (MCI) transition to Alzheimer disease (AD), others develop non-AD dementia, remain in the MCI state, or improve.
AD (MCI-c), 7 remained stable (MCI-nc), and 7 improved (MCI-i). Patients with MCI-c had 9% smaller left and 13% smaller right mean hippocampal volumes compared with MCI-nc patients. Radial atrophy maps showed greater atrophy of the CA1 subregion in MCI-c. Patients with MCI-c had significantly smaller hippocampi than MCI-i patients (left, 24%; right, 27%). Volumetric analyses showed a trend for greater hippocampal atrophy in MCI-nc relative to MCI-i patients (eg, 16% volume loss). After permutation tests corrected for multiple comparison, the atrophy maps showed a significant difference on the right. Subicular differences were seen between MCI-c and MCI-i patients, and MCI-nc and MCI-i patients. Multiple linear regression analysis confirmed the group effect to be highly significant and independent of age, hemisphere, and Mini-Mental State Examination scores at baseline.
Conclusions:
Smaller hippocampi and specifically CA1 and subicular involvement are associated with increased risk for conversion from MCI to AD. Patients with MCI-i tend to have larger hippocampal volumes and relative preservation of both the subiculum and CA1.
Arch Neurol. 2006; 63:693-699 M ILD COGNITIVE IMPAIRment (MCI) is an intermediate cognitive state between normal aging and dementia. Patients with amnestic MCI have memory decline while still enjoying functional lifestyles.
1,2 Most patients with amnestic MCI transition to Alzheimer disease (AD), dementia with Lewy bodies, or vascular dementia, but some remain stable and others improve. 3 Reversible MCI may be due to depression, adverse effects of medication, hormonal changes, or nonneurological conditions severe enough to affect cognition. 4 Any improvement in our ability to predict the outcome of MCI would be invaluable for counseling patients, making therapeutic decisions, and planning clinical trials. 5 Most amnestic MCI patients have AD pathology. 6, 7 In AD the pathology typically appears first in the entorhinal cortex, followed by the hippocampus and later the neocortex. Hippocampal atrophy correlates strongly with Braak and Braak pathological staging 8, 9 and cognitive decline, 8, 10, 11 and predates conversion to MCI in the oldest old (Ն85 years). 12 The MCI outcomes correlate with annualized hippocampal atrophy rates. The annual atrophy rates for those who remain stable (MCI-nc) is 2.8% and for those who develop AD (MCI-c) is 3.7%. The latter is strikingly similar to the 3.5% to 4.0% observed in AD. 13, 14 Some researchers have found an association between smaller hippocampi and the observed annual conversion rate from MCI to AD, 15, 16 whereas oth-ers have not. [17] [18] [19] [20] Variable conversion rates, MCI sample heterogeneity, and variability in hippocampal volume may partly explain these conflicting results.
We analyzed hippocampal atrophy in MCI with a region-of-interest technique and a new hippocampal 3-dimensional (3-D) radial atrophy mapping approach 21 assessing for subregional structural deformations. The technique has proved sensitive and reliable in several neurodegenerative, [21] [22] [23] developmental, 24, 25 and psychiatric 26, 27 disorders, as well as in normal brain development 28 and temporal lobe epilepsy. 29 
METHODS

PATIENTS
All subjects were prospectively recruited at the University of California-Los Angeles Alzheimer's Disease Research Center according to the restrictions and policies of the university's institutional review board. We prospectively followed 20 amnestic MCI subjects prospectively for 3 years with detailed clinical and neuropsychological examinations. We used the following inclusion criteria: age 55 to 90 years, cognitive complaint, memory decline of at least 1. 
CLINICAL OUTCOME MEASURES
Three primary outcomes were defined: conversion to AD (MCI-c) according to the Diagnostic and Statistical Manual of Mental Disorders, forth edition 30 and the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria; cognitive improvement where patients no longer met criteria for MCI (MCIi); and cognitive stability where they remained in the MCI category during the 3 years of follow-up (MCI-nc). Diagnosis was determined by consensus decision among neurologists, psychiatrists, and neuropsychologists who reviewed all available clinical and neuropsychological information.
IMAGING DATA ACQUISITION AND ANALYSIS
Imaging data were collected on a 1.5-T Signa magnetic resonance imaging scanner (GE Medical Systems, Milwaukee, Wis) with the following protocol: 3-D spoiled gradient coronal acquisition perpendicular to the long axis of the hippocampus, repetition time, 28 milliseconds; echo time, 6 milliseconds; field of view, 220 mm; 256ϫ192 matrix; and slice thickness, 1.5 mm. Magnetic resonance images were scaled to match the ICBM53 (International Consortium for Brain Mapping) average brain imaging template using a 9-parameter linear transformation. 31 Image nonuniformities due to magnetic field inhomogeneities were eliminated. 32 Hippocampi were traced on contiguous coronal slices following a detailed, well-established protocol with high intrarater and interrater reliability. 33 When boundaries were ambiguous, a standard neuroanatomical atlas was consulted. 34 Tracings included the hippocampus proper, dentate gyrus, and subiculum. All traces were made in a blinded fashion with respect to the subjects' age, sex, and cognitive outcome. Region-of-interest volumetric data were extracted and analyzed statistically.
The hippocampal contours were split into top and bottom components and transformed into 3-D parametric surface mesh models with normalized spatial frequency of the surface points within and across brain slices. This step ensures precise comparison of anatomy between subjects and groups at each hippocampal surface point. For each outcome group, we performed group averaging of hippocampal representations and recorded the variation between corresponding surface points. A medial core (central line threading down the long axis of the hippocampus) was computed for each hippocampus. Hippocampal radial distance measures (ie, the distance from the medial core to each point on the hippocampal surface model) were estimated. These values were used to generate individual distance maps that were combined across subjects to produce group average distance maps for comparing surface morphology between the groups.
21 Figure 1 summarizes these methods. The 
STATISTICAL ANALYSES
The region-of-interest volumetric data were globally assessed for group effects using analysis of variance. Each group pair was first compared using the 2-sample t test with pooled variances, followed by a Tukey test correcting for multiple comparisons. Multiple linear regression analyses were performed controlling for group, age, and Mini-Mental State Examination score at baseline. The radial atrophy significance maps were subjected to permutation-based statistics using a threshold of PϽ.01 to ensure that the overall pattern of effects in the surface-based maps could not have been observed by chance alone. 21 
RESULTS
PRIMARY OUTCOME
Of the 20 MCI patients, 6 converted to AD (MCI-c), 7 remained stable (MCI-nc), and 7 improved (MCI-i). Demographic data are shown in Table 1 
REGION-OF-INTEREST VOLUMETRIC ANALYSES
We found a significant group effect for the hippocampal volumes in our MCI cohort using analysis of variance ( Two-sample t-test statistics with pooled variance showed significant differences between MCI-c and MCI-nc patients in the left hippocampal volume and a trend for significance on the right. Significant bilateral differences were found between MCI-c and MCI-i patients. After correction for multiple comparisons, the MCI-c vs MCI-i volume differences remained significant, whereas the MCI-nc vs MCI-i differences showed a trend for significance ( Table 2) . 
RADIAL ATROPHY MAP
To better understand the anatomical distribution of radial atrophy, we consulted 2 well-established sources 34, 35 and demarcated the main hippocampal subfields on the hippocampal surface (Figure 2A) . Statistical maps comparing the individual groups are shown in Figure 2B -D. We subjected the maps to stringent multiple comparisons using permutation testing at a threshold of PϽ.01. The MCI-c and MCI-nc patients differed in the extent of involvement of the CA1 hippocampal subregion. The MCI-nc patients had significantly greater atrophy in the subicular region of the left and the CA1 region of the right hippocampus relative to MCI-i patients. The MCI-c patients showed signifi- cantly greater CA1 and subicular involvement relative to MCI-i patients bilaterally. The CA2 and CA3 subfields showed no significant group differences ( Table 3) . Figure 3 depicts 3-D statistical maps correlating the delayed recall score on the California Verbal Learning Test with hippocampal radial atrophy. The strongest correlations were seen (or observed) for the lateral and ventral hippocampal surfaces (CA1 and subiculum).
COGNITIVE CORRELATIONS
COMMENT MCI-c showed a distinct pattern of hippocampal atrophy from MCI-nc and MCI-i. The magnetic resonance imaging preconversion difference at baseline is atrophy of the lateral edge of the hippocampal formation, possibly corresponding to the CA1 subfield. The baseline magnetic resonance imaging preconversion difference is atrophy of the lateral edge of the hippocampal formation, possibly corresponding to the CA1 subfield. As we expected, the CA2 and CA3 subfields did not show differences between the 3 groups, although a larger sample may be needed to detect subtle differences. The CA1 hippocampal subfield is particularly susceptible to neuronal loss in early AD. [36] [37] [38] One recent study demonstrated preferential CAI and subicular atrophy, and relative sparing of CA2, CA3, and CA4 subfields in the earliest pathologic AD stages (Braak states I-III). 39 Using a computational anatomy approach similar to ours, Wang et al 40 and Csernansky et al 41 compared hippocampal volume and shape between subjects with mild AD (Clinical Dementia Rating Scale score, 0.5) and age-matched control subjects. Their hippocampal deformation maps accurately distinguished subjects with AD from healthy controls. The AD group had lateral-edge atrophy in regions corresponding to the CA1 hippocampal subfield at baseline with spread to the hippocampal head at follow-up. Further extending their work, we found greater CA1 involvement in MCI patients who later developed AD. We found strong correlations between greater atrophy and verbal memory performance.
Some studies find that a proportion of MCI subjects revert back to normal cognition when followed up longitudinally. 3 To our knowledge, ours is the first imaging study that includes the whole spectrum of clinical outcomes of cognitive worsening, improvement, and stability. Patients with reversible MCI seem to have CA1 and subicular sparing and larger hippocampal volumes at baseline. The precise etiology for the amnestic syndrome in our MCI-i patients remains obscure as we excluded patients with depression or any other illness that could contribute to cognitive decline. Future studies focusing on MCI-i will help clarify its etiology. Our study has several limitations. Despite the small sample size, we were able to demonstrate significant morphological differences between the groups. A larger MCI patient sample will better define hippocampal regions that correlate best with cognitive outcomes and determine the specificity and sensitivity of our methods in predicting cognitive outcome in patients with newly diagnosed MCI. Without direct pathological validation, the interpretation of the subregional involvement remains arbitrary. The subregional boundaries we used are similar to those proposed by other research groups. 42, 43 Nevertheless, what we interpret as CA1 or subicular involvement may reflect changes in another hippocampal subregion. Our study focused on amnestic MCI. Our findings cannot be generalized to all MCI patients, especially to those with the nonamnestic subtype. A large prospective study that follows up patients with all MCI subtypes over time is needed to address the etiological, clinical, and prognostic questions that remain unanswered.
